Full-Life Technologies Disclosed Preclinical Data of its NTSR1-targeting RDC Program FL-091 in an Oral Presentation at the 2024 SNMMI Annual Meeting

/PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, released preclinical data of its NTSR1-targeting RDC...

Related Keywords

Germany ,Belgium ,Toronto ,Ontario ,Canada ,China ,Shanghai ,Heidelberg ,Baden Wüberg , ,Metro Toronto Convention Centre ,Society Of Nuclear Medicine ,Life Technologies ,Nuclear Medicine ,Molecular Imaging ,Annual Meeting ,